NCT00090181已完成4 期
A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 401
- 主要终点
- Lower back pain intensity
研究概览
简要总结
The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition.
- •Patients should have at least 3 months of Low Back Pain.
排除标准
- 未提供
结局指标
主要结局
Lower back pain intensity
Safety and tolerability
次要结局
- Patient global assessment of response to therapy
- Disability questionnaire
研究者
相似试验
已完成
3 期
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)Benign Prostatic HyperplasiaNCT00127179Organon and Co600
已完成
2 期
A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)OsteoarthritisNCT00296569Merck Sharp & Dohme LLC150
已完成
2 期
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)Diabetic Neuropathy, PainfulNCT01564459Merck Sharp & Dohme LLC170
已完成
2 期
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia GravisMyasthenia GravisNCT03052751UCB Biopharma S.P.R.L.43
已完成
3 期
A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)Paget's Disease of BoneNCT00480662Organon and Co60